You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 3
  • 917 Phase 1b trial of first-line bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, plus chemotherapy with or without bevacizumab in cervical cancer

Citation Tools

Article menu

Download PDFPDF

Cervical cancer
917 Phase 1b trial of first-line bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, plus chemotherapy with or without bevacizumab in cervical cancer
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Oaknin A, Gil-Martin M, Diver E, et al
917 Phase 1b trial of first-line bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, plus chemotherapy with or without bevacizumab in cervical cancer
International Journal of Gynecologic Cancer 2021;31:A51-A52.